FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000PH2JNJ4

Market Closed - Deutsche Boerse AG 01:20:30 15/06/2024 am IST
8.02 EUR 0.00% Intraday chart for FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month-0.99%
1 month-6.42%
Date Price Change
14/24/14 8.02 0.00%
13/24/13 8.02 +0.88%
12/24/12 7.95 -2.45%
11/24/11 8.15 -0.49%
10/24/10 8.19 +0.37%

Delayed Quote Deutsche Boerse AG

Last update June 15, 2024 at 01:20 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PH2JNJ
ISINDE000PH2JNJ4
Date issued 27/02/2020
Strike 145.4 $
Maturity Unlimited
Parity 1 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 15.29
Lowest since issue 5.73
Spread 0.02
Spread %0.25%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
145.5 USD
Average target price
171.7 USD
Spread / Average Target
+17.99%
Consensus